Menu Back toSession 4: Strategies for Managing Complex Digital Health Data Sets for Successful Regulatory Submissions

Digital Technology in Clinical Trials Conference

Digital Technology in Clinical Trials Conference is now fully virtual. Join us from the comfort of your own space!


Session 4: Strategies for Managing Complex Digital Health Data Sets for Successful Regulatory Submissions

Session Chair(s)

Rachel  Chasse, MS

Rachel Chasse, MS

  • Digital Operations Lead
  • AbbVie, United States
Clinical research has entered the world of digital health technologies (DHT), but what happens when large datasets are full of holes? In this session, leaders will discuss best practices on how to strategically manage large data sets: from how to plan for variability to accounting for adherence challenges and everything in between. In this session, we will discuss how data management strategies addressing these topics can support successful regulatory submissions.
Learning Objective : At the conclusion of this session, participants should be able to:
  • Deploy proactive approaches to collecting and ingesting large data sets
  • Discuss realistic expectations for analyzing data before collecting begins
  • Identify data management strategies for managing voluminous continuous data

Speaker(s)

Aman  Thukral, MPharm, MS

Speakers

Aman Thukral, MPharm, MS

  • Head of Digital Operations & Clinical Systems Data and Statistical Science (DSS)
  • AbbVie, Inc., United States
Jennifer  Goldsack, MA, MBA, MS

Managing Complex Digital Health Data Sets for Successful Regulatory Submissions

Jennifer Goldsack, MA, MBA, MS

  • Chief Executive Officer
  • Digital Medicine Society (DiMe), United States
Wenyi  Lin, PhD, MS

Considerations to Address Missing Data When Deriving Clinical Trial Endpoints from Digital Health Technologies

Wenyi Lin, PhD, MS

  • Manager, Biostatistics, Digital Sciences and Translational Imaging (DSTI)
  • Pfizer, United States